On August 11, 2020, the U.S. Court of Appeals for the Ninth Circuit decisively reversed the Federal Trade Commission’s (FTC or Commission) controversial district court win challenging Qualcomm’s licensing practices. In...more
8/18/2020
/ Anticompetitive Behavior ,
Antitrust Violations ,
Appeals ,
Cell Phones ,
Corporate Counsel ,
Federal Trade Commission (FTC) ,
FRAND ,
FTC Act ,
Injunctive Relief ,
Intellectual Property Protection ,
IP License ,
Lack of Evidence ,
Monopolization ,
OEM ,
Patent Royalties ,
Qualcomm ,
Remand ,
Reversal ,
Sherman Act ,
Standard Essential Patents
On April 22, 2020, the Third Circuit Court of Appeals vacated and remanded an order certifying a class of direct purchaser plaintiffs in In re: Lamictal Direct Purchaser Antitrust Litigation, holding that the district court...more
4/30/2020
/ Antitrust Injuries ,
Antitrust Litigation ,
Appeals ,
Burden of Proof ,
Class Certification ,
Delays ,
Direct Purchasers ,
FRCP 23 ,
FRCP 23(b)(3) ,
Generic Drugs ,
Manufacturers ,
Pharmaceutical Industry ,
Predominance Requirement ,
Remand ,
Reverse Payment Settlement Agreements ,
Vacated ,
Wholesale